Rochelle Walensky served as the director of the Centers for Disease Control and Prevention. Benjamin Rader is the scientific director of the innovation group at Boston Children’s Hospital.
In the coming weeks, millions of families will pass through crowded airports to visit relatives for the holidays, but this year those routine trips carry a heightened risk for infants. Earlier this month, a 7-month-old in New York died after contracting measles. Around the same time, an infant in Wisconsin also died after acquiring the illness. The two cases are among 10 measles-related deaths in the United States already this year.
National guidance has failed to catch up to this new domestic landscape, leaving nearly 2 million U.S. infants vulnerable as the nation heads into the busiest travel season of the year.
An infant’s death from measles is almost entirely preventable. The measles, mumps and rubella (MMR) vaccine is extraordinarily effective at preventing measles and severe disease, and it has been shown to be safe for children as young as 6 months. When given this early, it acts as an extra “zero dose” — so called because it precedes, but does not replace, the standard two-dose series traditionally begun at 12 months. But the child in New York, like most 7-month-olds across the country, was likely never offered one.
Measles is one of the world’s most contagious viruses, but the current MMR guidelines were written when it was considered a threat from abroad, and for most of the past few decades, this was true. Because of the focus on international importation rather than local spread, zero doses have traditionally been offered only to infants traveling internationally or living in outbreak settings.
But with measles detected in 45 states and D.C. this year, domestic exposure is no longer an anomaly, and federal guidelines need to evolve to confront this reality.
In 2019, over 95 percent of kindergartners had received the MMR vaccine, and most infants were protected by the resulting blanket of herd immunity. But with gaps in vaccine coverage emerging nationwide, crowded transit hubs act as mixing zones where any presymptomatic traveler can expose a vulnerable infant regardless of final destination.
The Centers for Disease Control and Prevention recommends children receive their first MMR vaccine between 12 and 15 months of age, and their second between 4 and 6 years. Infants rely on passive immunity from their mothers, but that protection typically wanes around 6 months. Infants between 6 and 11 months remain almost entirely susceptible. Despite their vulnerability, infants have traditionally begun the MMR vaccine series at 12 months because their chances of measles exposure were vanishingly low. However, with over 5,000 cases this year in the U.S., this gap has proven deadly. In a JAMA article co-authored with John Brownstein and Wesley Rogers, we argue that recommendations for zero doses should be broadened to close it.
As states attempt to respond to the ongoing measles outbreak, their approaches to zero doses have been highly inconsistent. Some states, such as New York, now recommend a zero dose for any infant living in or visiting a community with measles transmission, while others, such as Florida, have issued no guidance beyond the narrow federal criteria, despite months of active community spread.
Unsure how to navigate this patchwork, clinicians and parents are searching for answers.
Anonymous, aggregate clinical search trends shared with us by the medical reference tool OpenEvidence highlight the widespread confusion. Query themes include uncertainty about what officially constitutes an outbreak and whether every 6-month-old automatically qualifies for a zero dose. The platform has already logged questions related to zero doses from more than 15,000 providers this year. Faced with ambiguous guidance and inconsistent messaging about eligibility, clinicians will likely default to the routine timeline.
Michigan has demonstrated how guidelines can motivate action. Following outbreaks in Washtenaw and Monroe counties, the state health department revised its policy to recommend a zero dose for any infant living in or traveling to the outbreak area, as well as for infants residing in the surrounding counties. In about six weeks, more than 2,300 babies received a zero dose, three times as many as during the same period a year earlier.
In the absence of a functioning Advisory Committee on Immunization Practices — the independent body of experts that issues evidence-based vaccine guidelines for the U.S. — we are encouraging pediatricians and parents to recognize the current domestic measles risk and to protect their infants accordingly.
Stopping the spread of measles and restoring herd immunity through vaccination will take time, but protecting infants from the disease is a problem we can solve today. The MMR vaccine is safe, effective and available. If you care for an infant 6 to 11 months old who is eligible, request or administer an MMR vaccine before the child travels this year. Doing so ensures the holidays remain a time of family, celebration and togetherness without risking the preventable death of another child.
The post Measles is here. That demands a ‘zero dose.’ appeared first on Washington Post.




